Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
81
PharmaCompass offers a list of Ginger extract API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ginger extract manufacturer or Ginger extract supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ginger extract manufacturer or Ginger extract supplier.
PharmaCompass also assists you with knowing the Ginger extract API Price utilized in the formulation of products. Ginger extract API Price is not always fixed or binding as the Ginger extract Price is obtained through a variety of data sources. The Ginger extract Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ginger extract (Zingiber officinale) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ginger extract (Zingiber officinale), including repackagers and relabelers. The FDA regulates Ginger extract (Zingiber officinale) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ginger extract (Zingiber officinale) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ginger extract (Zingiber officinale) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ginger extract (Zingiber officinale) supplier is an individual or a company that provides Ginger extract (Zingiber officinale) active pharmaceutical ingredient (API) or Ginger extract (Zingiber officinale) finished formulations upon request. The Ginger extract (Zingiber officinale) suppliers may include Ginger extract (Zingiber officinale) API manufacturers, exporters, distributors and traders.
click here to find a list of Ginger extract (Zingiber officinale) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ginger extract (Zingiber officinale) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ginger extract (Zingiber officinale) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ginger extract (Zingiber officinale) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ginger extract (Zingiber officinale) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ginger extract (Zingiber officinale) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ginger extract (Zingiber officinale) suppliers with NDC on PharmaCompass.
Ginger extract (Zingiber officinale) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ginger extract (Zingiber officinale) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ginger extract (Zingiber officinale) GMP manufacturer or Ginger extract (Zingiber officinale) GMP API supplier for your needs.
A Ginger extract (Zingiber officinale) CoA (Certificate of Analysis) is a formal document that attests to Ginger extract (Zingiber officinale)'s compliance with Ginger extract (Zingiber officinale) specifications and serves as a tool for batch-level quality control.
Ginger extract (Zingiber officinale) CoA mostly includes findings from lab analyses of a specific batch. For each Ginger extract (Zingiber officinale) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ginger extract (Zingiber officinale) may be tested according to a variety of international standards, such as European Pharmacopoeia (Ginger extract (Zingiber officinale) EP), Ginger extract (Zingiber officinale) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ginger extract (Zingiber officinale) USP).
